Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9646)
All Articles published online
|
Publishing Process of This Article
|
May 21, 2014 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vaz J, Andersson R. Intervention on toll-like receptors in pancreatic cancer. World J Gastroenterol 2014; 20(19): 5808-5817 [PMID: 24914341 DOI: 10.3748/wjg.v20.i19.5808] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5808.htm |
| Number | Citing Articles |
| 1 |
Tanja Grimmig, Romana Moench, Jennifer Kreckel, Stephanie Haack, Felix Rueckert, Roberta Rehder, Sudipta Tripathi, Carmen Ribas, Anil Chandraker, Christoph Germer, Martin Gasser, Ana Waaga-Gasser. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. International Journal of Molecular Sciences 2016; 17(12): 2060 doi: 10.3390/ijms17122060
|
| 2 |
Paige M. Bracci. Oral Health and the Oral Microbiome in Pancreatic Cancer. The Cancer Journal 2017; 23(6): 310 doi: 10.1097/PPO.0000000000000287
|
| 3 |
Maaike R. Scheenstra, Roel M. van Harten, Edwin J. A. Veldhuizen, Henk P. Haagsman, Maarten Coorens. Cathelicidins Modulate TLR-Activation and Inflammation. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01137
|
| 4 |
E. Fehri, E. Ennaifer, R. Bel Haj Rhouma, L. Guizani-Tabbane, I. Guizani, S. Boubaker. The role of Toll-like receptor 9 in gynecologic cancer. Current Research in Translational Medicine 2016; 64(3): 155 doi: 10.1016/j.retram.2016.01.010
|
| 5 |
JebaMercy Gnanasekaran, Adi Binder Gallimidi, Elias Saba, Karthikeyan Pandi, Luba Eli Berchoer, Esther Hermano, Sarah Angabo, Hasna′a Makkawi, Arin Khashan, Alaa Daoud, Michael Elkin, Gabriel Nussbaum. Intracellular Porphyromonas gingivalis Promotes the Tumorigenic Behavior of Pancreatic Carcinoma Cells. Cancers 2020; 12(8): 2331 doi: 10.3390/cancers12082331
|
| 6 |
Anna Maria Nurmi, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund, Girijesh Kumar Patel. The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy. PLOS ONE 2022; 17(5): e0267792 doi: 10.1371/journal.pone.0267792
|
| 7 |
Dominique S. Michaud. Gastrointestinal Diseases and their Associated Infections. 2019; : 125 doi: 10.1016/B978-0-323-54843-4.00010-6
|
| 8 |
Max Schnurr, Peter Duewell, Christian Bauer, Simon Rothenfusser, Kirsten Lauber, Stefan Endres, Sebastian Kobold. Strategies to Relieve Immunosuppression in Pancreatic Cancer. Immunotherapy 2015; 7(4): 363 doi: 10.2217/imt.15.9
|
| 9 |
Concetta Panebianco, Valerio Pazienza. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology. Critical Reviews in Clinical Laboratory Sciences 2019; 56(4): 260 doi: 10.1080/10408363.2019.1615407
|
| 10 |
Daniel S.K. Liu, Jisce R. Puik, Morten T. Venø, Mireia Mato Prado, Eleanor Rees, Bhavik Y. Patel, Nabeel Merali, Daniel Galloway, Grace Chan, Natalie Phillips, Christopher Wadsworth, Panagiotis Vlavianos, Jonathan Potts, Shivan Sivakumar, Brian R. Davidson, Marc G. Besselink, Rutger-Jan Swijnenburg, Long R. Jiao, Geert Kazemier, Elisa Giovannetti, Jonathan Krell, Adam E. Frampton. MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study. International Journal of Surgery 2024; 110(10): 6518 doi: 10.1097/JS9.0000000000001888
|
| 11 |
Yupeng Yan, Bin Lu, Pengyang Li, Ji Wang. NOD receptor and TLR9 modulation in severe acute pancreatitis-induced intestinal injury. Molecular Medicine Reports 2017; 16(6): 8471 doi: 10.3892/mmr.2017.7661
|
| 12 |
Stephanie H. Greco, Lena Tomkötter, Anne-Kristin Vahle, Rae Rokosh, Antonina Avanzi, Syed Kashif Mahmood, Michael Deutsch, Sara Alothman, Dalia Alqunaibit, Atsuo Ochi, Constantinos Zambirinis, Tasnima Mohaimin, Mauricio Rendon, Elliot Levie, Mridul Pansari, Alejandro Torres-Hernandez, Donnele Daley, Rocky Barilla, H. Leon Pachter, Daniel Tippens, Hassan Malik, Allal Boutajangout, Thomas Wisniewski, George Miller, Ajay Pratap Singh. TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. PLOS ONE 2015; 10(7): e0132786 doi: 10.1371/journal.pone.0132786
|
| 13 |
Ender Anılır, Filiz Özen, İbrahim Halil Yıldırım. Effects of toll like receptor 4 (TLR4) and toll like receptor 2 (TLR 2) gene polymorphisms on clinical outcomes in acute non-biliary pancreatitis patients. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1427187
|
| 14 |
Amrendra K. Ajay, Martin Gasser, Li-Li Hsiao, Thomas Böldicke, Ana Maria Waaga-Gasser. TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth. Antibodies 2024; 13(1): 11 doi: 10.3390/antib13010011
|
| 15 |
Eylem Taskin, Celal Guven, Salih Tunc Kaya, Leyla Sahin, Sayad Kocahan, Arife Zuhal Degirmencioglu, Fatih Mehmet Gur, Yusuf Sevgiler. The role of toll-like receptors in the protective effect of melatonin against doxorubicin-induced pancreatic beta cell toxicity. Life Sciences 2019; 233: 116704 doi: 10.1016/j.lfs.2019.116704
|
| 16 |
Shipra Das, Beny Shapiro, Emily A. Vucic, Sandra Vogt, Dafna Bar-Sagi. Tumor Cell–Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer. Cancer Research 2020; 80(5): 1088 doi: 10.1158/0008-5472.CAN-19-2080
|
| 17 |
Cindy Patinote, Nour Bou Karroum, Georges Moarbess, Natalina Cirnat, Issam Kassab, Pierre-Antoine Bonnet, Carine Deleuze-Masquéfa. Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes. European Journal of Medicinal Chemistry 2020; 193: 112238 doi: 10.1016/j.ejmech.2020.112238
|
| 18 |
Rachel Goldberg, Amichay Meirovitz, Alexia Abecassis, Esther Hermano, Ariel M. Rubinstein, Daniela Nahmias, Albert Grinshpun, Tamar Peretz, Michael Elkin. Regulation of Heparanase in Diabetes-Associated Pancreatic Carcinoma. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01405
|
| 19 |
Sooram Banesh, Nupoor Patil, Vihadhar Reddy Chethireddy, Arnav Bhukmaria, Prakash Saudagar. Design and evaluation of a multiepitope vaccine for pancreatic cancer using immune-dominant epitopes derived from the signature proteome in expression datasets. Medical Oncology 2024; 41(5) doi: 10.1007/s12032-024-02334-4
|
| 20 |
Alvaro G. Alvarado, Justin D. Lathia. Taking a Toll on Self-Renewal: TLR-Mediated Innate Immune Signaling in Stem Cells. Trends in Neurosciences 2016; 39(7): 463 doi: 10.1016/j.tins.2016.04.005
|
| 21 |
Giacomo Baima, Davide Giuseppe Ribaldone, Mamdouh Muwalla, Federica Romano, Filippo Citterio, Angelo Armandi, Mario Aimetti. Can Periodontitis Affect the Health and Disease of the Digestive System? A Comprehensive Review of Epidemiological Evidence and Biological Mechanisms. Current Oral Health Reports 2021; 8(4): 96 doi: 10.1007/s40496-021-00302-9
|
| 22 |
John P. Neoptolemos, Jörg Kleeff, Patrick Michl, Eithne Costello, William Greenhalf, Daniel H. Palmer. Therapeutic developments in pancreatic cancer: current and future perspectives. Nature Reviews Gastroenterology & Hepatology 2018; 15(6): 333 doi: 10.1038/s41575-018-0005-x
|
| 23 |
Joanne Lundy, Linden J. Gearing, Hugh Gao, Alison C. West, Louise McLeod, Virginie Deswaerte, Liang Yu, Sean Porazinski, Marina Pajic, Paul J. Hertzog, Daniel Croagh, Brendan J. Jenkins. TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma. Oncogene 2021; 40(41): 6007 doi: 10.1038/s41388-021-01992-2
|
| 24 |
Giacomo Baima, Davide Ribaldone, Federica Romano, Mario Aimetti, Mario Romandini. The Gum–Gut Axis: Periodontitis and the Risk of Gastrointestinal Cancers. Cancers 2023; 15(18): 4594 doi: 10.3390/cancers15184594
|
| 25 |
Fariborz Bahrami, Filip Kukulski, Joanna Lecka, Alain Tremblay, Julie Pelletier, Liliana Rockenbach, Jean Sévigny. Purine-Metabolizing Ectoenzymes Control IL-8 Production in Human Colon HT-29 Cells. Mediators of Inflammation 2014; 2014: 1 doi: 10.1155/2014/879895
|
| 26 |
Xuelian Chen, Fang Cheng, Yanfang Liu, Lirong Zhang, Lian Song, Xiaojie Cai, Tao You, Xin Fan, Dongqing Wang, Aihua Gong, Haitao Zhu. Toll-like receptor 2 and Toll-like receptor 4 exhibit distinct regulation of cancer cell stemness mediated by cell death-induced high-mobility group box 1. EBioMedicine 2019; 40: 135 doi: 10.1016/j.ebiom.2018.12.016
|
| 27 |
Rossana Domenis, Adriana Cifù, Daniele Marinò, Martina Fabris, Kayvan R. Niazi, Patrick Soon-Shiong, Francesco Curcio. Toll-like Receptor-4 Activation Boosts the Immunosuppressive Properties of Tumor Cells-derived Exosomes. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-44949-y
|
| 28 |
Rui Lin, Yufeng Wang, Quanning Chen, Zhongyan Liu, Shuai Xiao, Bingyi Wang, Baomin Shi. TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8816
|
| 29 |
Santhosh Kalash Rajendrakumar, Saji Uthaman, Chong-Su Cho, In-Kyu Park. Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment. Biomacromolecules 2018; 19(6): 1869 doi: 10.1021/acs.biomac.8b00460
|
| 30 |
Kubra Sena Bas Topcu, Emine Nedime Korucu, Esma Menevse, Nadir Kocak, Tugce Duran. Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint vista in pancreatic cancer. Investigational New Drugs 2022; 40(3): 519 doi: 10.1007/s10637-021-01209-z
|
| 31 |
Joni Leppänen, Olli Helminen, Heikki Huhta, Joonas H. Kauppila, Joel Isohookana, Kirsi-Maria Haapasaari, Petri Lehenkari, Juha Saarnio, Tuomo J. Karttunen. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Archiv 2017; 470(4): 401 doi: 10.1007/s00428-017-2087-1
|
| 32 |
Darya Javadrashid, Amir Baghbanzadeh, Nima Hemmat, Khalil Hajiasgharzadeh, Niloufar Sadat Nourbakhsh, Ziba Lotfi, Behzad Baradaran. Envisioning the immune system to determine its role in pancreatic ductal adenocarcinoma: Culprit or victim?. Immunology Letters 2021; 232: 48 doi: 10.1016/j.imlet.2021.02.009
|
| 33 |
Joni Leppänen, Olli Helminen, Heikki Huhta, Joonas H. Kauppila, Joel Isohookana, Kirsi‐Maria Haapasaari, Peeter Karihtala, Seppo Parkkila, Juha Saarnio, Petri P. Lehenkari, Tuomo J. Karttunen. Toll‐like receptors 2, 4 and 9 and hypoxia markers HIF‐1alpha and CAIX in pancreatic intraepithelial neoplasia. APMIS 2018; 126(11): 852 doi: 10.1111/apm.12894
|
| 34 |
Makena J. Binker-Cosen, Daniel Richards, Brenda Oliver, Herbert Y. Gaisano, Marcelo G. Binker, Laura I. Cosen-Binker. Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4/ROS/NF-κB/MMP-9 signaling pathway. Biochemical and Biophysical Research Communications 2017; 484(1): 152 doi: 10.1016/j.bbrc.2017.01.051
|
| 35 |
Ling-Wei Hii, Swee-Hua Erin Lim, Chee-Onn Leong, Swee-Yee Chin, Ngai-Paing Tan, Kok-Song Lai, Chun-Wai Mai. The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2663-9
|
| 36 |
Eileen Carpenter, Sarah Nelson, Filip Bednar, Clifford Cho, Hari Nathan, Vaibhav Sahai, Marina Pasca di Magliano, Timothy L. Frankel. Immunotherapy for pancreatic ductal adenocarcinoma. Journal of Surgical Oncology 2021; 123(3): 751 doi: 10.1002/jso.26312
|
| 37 |
Burles A. Johnson, Mark Yarchoan, Valerie Lee, Daniel A. Laheru, Elizabeth M. Jaffee. Strategies for Increasing Pancreatic Tumor Immunogenicity. Clinical Cancer Research 2017; 23(7): 1656 doi: 10.1158/1078-0432.CCR-16-2318
|
| 38 |
Katharina Beyer, Lars Ivo Partecke, Felicitas Roetz, Herbert Fluhr, Frank Ulrich Weiss, Claus-Dieter Heidecke, Wolfram von Bernstorff. LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0139-4
|
| 39 |
Yihan Chai, Zhengze Huang, Xuqiu Shen, Tianyu Lin, Yiyin Zhang, Xu Feng, Qijiang Mao, Yuelong Liang. Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response. Microorganisms 2023; 11(5): 1240 doi: 10.3390/microorganisms11051240
|
| 40 |
Arturo Orlacchio, Pellegrino Mazzone. The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology. International Journal of Molecular Sciences 2021; 22(23): 12743 doi: 10.3390/ijms222312743
|